0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Acute Lymphocytic Leukemia in Children:  Maintenance Therapy With Methotrexate Administered Intermittently

JAMA. 1969;207(5):923-928. doi:10.1001/jama.1969.03150180053011.
Text Size: A A A
Published online

Among 108 children under 20 years of age with acute lymphocytic leukemia, vincristine sulfate and prednisone induced complete remissions in 96% (43) of the patients with newly diagnosed disease and in 83% (52) of the previously treated patients. Methotrexate administered orally or intramuscularly twice a week maintained the remissions similarly. The median duration of remission for 42 newly treated patients was 10.4 months (orally) versus 8.9 months (intramuscularly), and for 51 previously treated patients it was 5.1 months (orally) and 4.9 months (intramuscularly). The duration of methotrexate-maintained remission was shorter for subsequent remissions especially if a previous remission had been maintained with methotrexate. Possibility of a new type of toxic reaction occurring during methotrexate maintenance is suggested by the high frequency of pneumonitis (38 of 93 children). Other toxic manifestations were controlled by diminished dosages of methotrexate.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();